Author: Daniel S, PhD; Last update: January 31st, 2021 Dear Friends, I just came across a recently published paper by scientists and MDs in oncology that deserves to be addressed in a post on this Blog. The scientific results come from MD Anderson Cancer Center & University of Alabama at Birmingham in USA, as wellContinue reading A Lower Cost Alternative to (anti PD1/PDL1) Immunotherapy?
